AFLURIA (bioCSL Pty Ltd.)


Welcome to the PulseAid listing for the AFLURIA drug offered from bioCSL Pty Ltd.. This Inactivated Influenza A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: bioCSL Pty Ltd.
NON-PROPRIETARY NAME: INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASS
SUBSTANCE NAME: INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRU
TYPE: VACCINE
PHARMA CLASS: Inactivated Influenza A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2011-07-15
END MARKETING DATE: 0000-00-00


AFLURIA VACCINE Details:

Item DescriptionAFLURIA from bioCSL Pty Ltd.
LABELER NAME: bioCSL Pty Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2011-07-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 33332-015_91776d76-04ff-438a-84a8-08d54e161ae0
PRODUCT NDC: 33332-015
APPLICATION NUMBER: BLA125254

Other INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRU Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
bioCSL Pty Ltd.AFLURIA